Poh Seng Tan

1.7k total citations
26 papers, 541 citations indexed

About

Poh Seng Tan is a scholar working on Hepatology, Epidemiology and Cancer Research. According to data from OpenAlex, Poh Seng Tan has authored 26 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 14 papers in Epidemiology and 6 papers in Cancer Research. Recurrent topics in Poh Seng Tan's work include Liver Disease Diagnosis and Treatment (8 papers), Hepatitis B Virus Studies (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Poh Seng Tan is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Hepatitis B Virus Studies (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Poh Seng Tan collaborates with scholars based in Singapore, United States and Japan. Poh Seng Tan's co-authors include Yujin Hoshida, Xintong Chen, Xiaochen Sun, Maria Isabel Fiel, Guan Huei Lee, Manjeet Deshmukh, Anu Venkatesh, Eng Kiong Teo, Tiing Leong Ang and Claudia Canasto‐Chibuque and has published in prestigious journals such as Gastroenterology, PLoS ONE and Development.

In The Last Decade

Poh Seng Tan

25 papers receiving 537 citations

Peers

Countries citing papers authored by Poh Seng Tan

Since Specialization

Citations

This map shows the geographic impact of Poh Seng Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Poh Seng Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Poh Seng Tan more than expected).

Fields of papers citing papers by Poh Seng Tan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Poh Seng Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Poh Seng Tan. The network helps show where Poh Seng Tan may publish in the future.

Co-authorship network of co-authors of Poh Seng Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Poh Seng Tan. A scholar is included among the top collaborators of Poh Seng Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Poh Seng Tan. Poh Seng Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The role of biodegradable temporizing matrix in the management of a patient with major burns and anorexia nervosa 2022 ·Journal of Surgical Case Reports ·Poh Seng Tan, (unknown), (unknown), (unknown), (unknown)	1
2	Novel albumin, bilirubin and platelet criteria for the exclusion of high-risk varices in compensated advanced chronic liver disease: A validation study 2021 ·Clinics and Research in Hepatology and Gastroenterology ·Yu Jun Wong, Guan Sen Kew, Poh Seng Tan, Zhaojin Chen, (unknown), (unknown), Tiing Leong Ang, Kwong Ming Fock, Guan Huei Lee, John Hsiang, Daniel Q. Huang, Andrew Kwek, Mark Muthiah, Rahul Kumar, (unknown), Jessica Tan, Prem Harichander Thurairajah, Eng Kiong Teo, Bee Choo Tai, Seng Gee Lim	2
3	Switching to or Add-on Peginterferon in Patients on Nucleos(t)ide Analogues for Chronic Hepatitis B: The SWAP RCT 2021 ·Clinical Gastroenterology and Hepatology ·Seng Gee Lim, Wei Yang, Jing Hieng Ngu, Pik‐Eu Chang, Jessica Tan, Taufique Ahmed, Yock Young Dan, (unknown), Yin Mei Lee, Guan Huei Lee, Poh Seng Tan, Khin Lay Wai, (unknown), (unknown), Chris Lee, (unknown), Edwin Chan	26
4	The value of liquid biopsy in the diagnosis and staging of hepatocellular carcinoma: a systematic review 2021 ·Translational Gastroenterology and Hepatology ·Poh Seng Tan, Lisa Grundy, (unknown), (unknown), George Ramsay, Mohamed Bekheit	2
5	Nucleoside analog monotherapy for prophylaxis in Hepatitis B liver transplant patients is safe and efficacious 2020 ·Hepatology International ·Mark Muthiah, (unknown), (unknown), Daniel Q. Huang, Glenn Kunnath Bonney, Alfred Wei Chieh Kow, Seng Gee Lim, Yock Young Dan, Poh Seng Tan, Guan Huei Lee, (unknown)	11
6	Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic Chinese population 2020 ·World Journal of Hepatology ·Guan Huei Lee, (unknown), (unknown), Raymond Kwok, Taufique Ahmed, Asim Shabbir, Jimmy Bok Yan So, Calvin Jianyi Koh, Juanda Leo Hartono, Mark Muthiah, (unknown), Poh Seng Tan, Yin Mei Lee, Seng Gee Lim, Yock Young Dan	10
7	Identifying Patients With Cirrhosis Who Might Avoid Screening Endoscopy Based on Serum Albumin and Bilirubin and Platelet Counts 2019 ·Clinical Gastroenterology and Hepatology ·Guan Sen Kew, (unknown), (unknown), (unknown), (unknown), Yock Young Dan, (unknown), Daniel Q. Huang, Guan Huei Lee, Yin Mei Lee, Seng Gee Lim, (unknown), Mark Muthiah, Bee Choo Tai, Poh Seng Tan	6
8	Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infection 2019 ·World Journal of Hepatology ·(unknown), (unknown), (unknown), Poh Seng Tan, (unknown), Yock Young Dan, Yin Mei Lee, Mark Muthiah, (unknown), Calvin Jianyi Koh, (unknown), Junxiong Pang, Seng Gee Lim, Guan Huei Lee	6
9	Asian Liver Transplant Network Clinical Guidelines on Immunosuppression in Liver Transplantation 2018 ·Transplantation ·Poh Seng Tan, Mark Muthiah, (unknown), Yee Leong Teoh, Albert Chan, Alfred Wei Chieh Kow, Qishi Zheng, Choon Hyuck David Kwon, Guan Huei Lee, Cosmas Rinaldi Adithya Lesmana, (unknown), James Fung, (unknown)	25
10	Does persistent anti-HBc positivity influence the prognosis of HBsAg-negative hepatocellular carcinoma? comparative outcomes of anti-Hbc positive versus anti-Hbc negative non-B non-C HCC 2018 ·HPB ·Jia Hao Law, (unknown), (unknown), (unknown), Poh Seng Tan, Glenn Kunnath Bonney, Shridhar Ganpathi Iyer, Krishnakumar Madhavan, (unknown)	3
11	Novel markers predict HBs-antigen seroclearance in chronic hepatitis B patients from the SWAP clinical trial 2018 ·Journal of Hepatology ·(unknown), Gavin Cloherty, Emily K. Butler, Mary C. Kuhns, Anne L. McNamara, Vera Holzmayer, (unknown), (unknown), Paul Chang, Jing Yuan Tan, (unknown), Yock Young Dan, (unknown), (unknown), Poh Seng Tan, Sim Yee Tan, (unknown), (unknown), Edwin Chan, Seng Gee Lim	1
12	Imaging-based surrogate markers of transcriptome subclasses and signatures in hepatocellular carcinoma: preliminary results 2017 ·European Radiology ·Bachir Taouli, Yujin Hoshida, Suguru Kakite, Xintong Chen, Poh Seng Tan, Xiaochen Sun, Shingo Kihira, Kensuke Kojima, Sara Toffanin, Maria Isabel Fiel, Hadassa Hirschfield, Mathilde Wagner, Josep M. Llovet	37
13	Predictors of Non-adherence to Immunosuppressive Therapy in Asian Liver Transplant Recipients 2017 ·Transplantation Proceedings ·Juanda Leo Hartono, (unknown), Guan Huei Lee, Poh Seng Tan, Mark Muthiah, Marion Aw, Krishnakumar Madhavan, Alfred Wei Chieh Kow, Kevin Boon Leong Lim	5
14	Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation 2015 ·Journal of Hepatology ·Oriana Miltiadous, Daniela Sia, Yujin Hoshida, Maria Isabel Fiel, Andrew Harrington, Swan N. Thung, Poh Seng Tan, Hui Dong, Kate Revill, Charissa Chang, Sasan Roayaie, Thomas Byrne, Vincenzo Mazzaferro, Jorge Rakela, Sander Florman, Myron Schwartz, Josep M. Llovet	63
15	DNA hypomethylation induces a DNA replication-associated cell cycle arrest to block hepatic outgrowth in uhrf1 mutant zebrafish embryos 2015 ·Development ·Vinitha Jacob, Yelena Chernyavskaya, Xintong Chen, Poh Seng Tan, (unknown), Yujin Hoshida, Kirsten C. Sadler	43
16	Clinicopathological indices to predict hepatocellular carcinoma molecular classification 2015 ·Liver International ·Poh Seng Tan, Shigeki Nakagawa, Nicolas Goossens, Anu Venkatesh, Tiangui Huang, Stephen C. Ward, Xiaochen Sun, Won‐Min Song, Anna P. Koh, Claudia Canasto‐Chibuque, Manjeet Deshmukh, Venugopalan D. Nair, Milind Mahajan, Bin Zhang, Maria Isabel Fiel, Masahiro Kobayashi, Hiromitsu Kumada, Yujin Hoshida	63
17	SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis 2014 ·British Journal of Cancer ·Cristian Turato, Alessandro Vitale, Silvano Fasolato, Mariagrazia Ruvoletto, Liliana Terrin, Santina Quarta, Rafael Morales, Alessandra Biasiolo, Giacomo Zanus, Narges Zali, Poh Seng Tan, Yujin Hoshida, (unknown), Umberto Cillo, Patrizia Pontisso	50
18	Transcriptome Profiling of Archived Sectioned Formalin-Fixed Paraffin-Embedded (AS-FFPE) Tissue for Disease Classification 2014 ·PLoS ONE ·Kensuke Kojima, Craig April, Claudia Canasto‐Chibuque, Xintong Chen, Manjeet Deshmukh, Anu Venkatesh, Poh Seng Tan, Masahiro Kobayashi, Hiromitsu Kumada, (unknown), Yujin Hoshida	40
19	Do different lamivudine‐resistant hepatitis B genotypes carry the same risk of entecavir resistance? 2012 ·Journal of Medical Virology ·Guan Huei Lee, Myat Oo Aung, Yock Young Dan, Yin Mei Lee, (unknown), (unknown), (unknown), (unknown), Poh Seng Tan, Seng Gee Lim	6
20	A comparison of surgery versus transcatheter angiographic embolization in the treatment of nonvariceal upper gastrointestinal bleeding uncontrolled by endoscopy 2012 ·European Journal of Gastroenterology & Hepatology ·Daphne Ang, Eng Kiong Teo, Andrew Tan, (unknown), Poh Seng Tan, Tiing Leong Ang, Kwong Ming Fock	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact